Abstract:Background The cytochrome P450, family 1, subfamily A, polypeptide 1 ( CYP1A1 ) gene is expressed in the vascular endothelium, which metabolizes arachidonic acid into 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatrienoic acids (EETs). 20-HETE mediates cardiovascular homeostasis and growth response in vascular smooth muscle cells (VSMCs) as well as the anti-platelet effect. EETs are potent endogenous vasodilators and inhibitors of vascular inflammation. This study assessed the association between human CYP1A1 gene polymorphisms and coronary artery disease (CAD) in the Uygur and Han in China. Methods Two independent case–control studies that recruited Han (389 patients with CAD and 411 controls) and Uygur participants (293 patients with CAD and 408 controls) analyzed the relationship between CYP1A1 single nucleotide polymorphisms (SNPs: rs4886605, rs12441817, rs4646422 and rs1048943) and CAD. All patients with CAD and controls were genotyped for the four SNPs of CYP1A1 using TaqMan SNP genotyping assays. Results In the Uygur group, the distribution of the dominant model(CC vs CT + TT) of rs4886605 for the total sample and the males was significantly different between CAD patients and control participants (P = 0.001 and P = 0.012, respectively), The difference remained significant after a multivariate adjustment (P = 0.018, P = 0.015, respectively). The rs12441817 was also associated with CAD in a dominant model for all participants (P = 0.003) and men (P = 0.012), and the difference remained significant after a multivariate adjustment (P = 0.016, P = 0.002, respectively). However, we did not observe differences in the Uygur females and Han group with regard to the allele frequency or genotypic distribution of rs4886605 and rs12441817 between patients with CAD and control participants. Patients with CAD did not significantly differ from the control participants with regard to the distributions of rs4646422 and rs1048943 genotypes, the dominant model, the recessive model, or allele frequency in the Han and Uygur groups. Conclusion Both rs4886605 and rs12441817 SNPs of the CYP1A1 gene are associated with CAD in the Uygur population of China.

Association Between Cytochrome P450 2C19 Polymorphism and Clinical Outcomes in Chinese Patients with Coronary Artery Disease

The Value of Combining Cyp2c19*2 Polymorphism with Classic Risk Factors in Prediction of Clinical Prognosis in Acute Coronary Syndrome Patients

Association of Genetic Variants in CYP2C19 and Adverse Clinical Outcomes after Treatment with Clopidogrel: an Updated Meta-Analysis

E0080 the CYP2J2 G50T Polymorphism and the Risk of Coronary Artery Disease in Han Chinese Population

A Functional Polymorphism in the Cyp3a4 Gene is Associated with Increased Risk of Coronary Heart Disease in the Chinese Han Population

The CYP2C19 genotype does not impact the long-term prognosis of patients with coronary artery disease.

A Novel Polymorphism of the CYP2J2 Gene is Associated with Coronary Artery Disease in Uygur Population in China.

Cytochrome P450 2C19 Polymorphism is Associated with Poor Clinical Outcomes in Coronary Artery Disease Patients Treated with Clopidogrel

Relationship of CYP2C192 and CYP2C193 Gene Polymorphism with Clopidogrel Response Variability and Recurrent Cardiovascular Events in Chinese Patients Undergoing Percutaneous Coronary Intervention.

The Effects of Cyp2c19 Genotype on the Susceptibility for Nephrosis in Cardio-Cerebral Vascular Disease Treated by Anticoagulation

Association between CYP2C19 polymorphisms and clinical outcomes in patients undergoing stent procedure for cerebral artery stenosis

The Cytochrome P450 2C19 Polymorphism Associated with Major Adverse Cardiovascular Events Risk in Kazak Patients Undergoing Percutaneous Coronary Intervention and Receiving Clopidogrel

GW24-e0980 A Novel Polymorphism of the CYP2J2 Gene is Associated with Coronary Heart Disease in Uygur Population in China

Association of Interaction Between Smoking and Cyp 2c19*3 Polymorphism with Coronary Artery Disease in A Uighur Population

Erratum to: The association between CYP1A1 genetic polymorphisms and coronary artery disease in the Uygur and Han of China

Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention

Cytochrome P450 family 4 subfamily F member 2 (CYP4F2) rs1558139, rs2108622 polymorphisms and susceptibility to several cardiovascular and cerebrovascular diseases

Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus assessed by follow-up optical coherence tomography in Chinese patients receiving clopidogrel

Effect of CYP2C19 polymorphism on platelet P2Y12 receptor signaling pathway in Chinese patients with stable coronary artery disease after the treatment of clopidogrel

CYP2C19 LOSS-OF-FUNCTION POLYMORPHISMS, STENT THROMBOSISIN, BLEEDING EVENTS, AND MORTALITY IN PATIENTS WITH CORONARY STENT PLACEMENT

Relationship Between CYP17A1 Genetic Polymorphism and Coronary Artery Disease in a Chinese Han Population